Author

Liisa van Vliet

University of CambridgeORCID 0000-0002-5196-7073Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:C. elegans· 1

Frequent Co-Authors

Fabrice GieleniD· 2 shared Florian HollfelderiD· 2 shared Alfonso De SimoneiD· 1 shared Ana Luísa RibeiroiD· 1 shared Aurélio HidalgoiD· 1 shared Chetan PoudeliD· 1 shared Claire H. Michel· 1 shared Clemens F. KaminskiiD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Fabrice GielenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyMicrobial Cell FactoriesPeer-reviewedJun 10, 2024

Thermostable in vitro transcription-translation for enzyme screening in microdroplets

Ana Luísa Ribeiro, Patricia Pérez-Arnaiz, Mercedes Sánchez‐Costa…·Aurélio Hidalgo

This paper develops a thermostable in vitro transcription-translation system using Thermus thermophilus extracts for enzyme screening in microdroplets.

9 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMar 28, 2022

A unified in vitro to in vivo fluorescence lifetime screening platform yields amyloid β aggregation inhibitors

Súil Collins, Liisa van Vliet, Fabrice Gielen…·Gabriele S. Kaminski Schierle

The paper develops a unified in vitro to in vivo fluorescence lifetime screening platform to identify amyloid β aggregation inhibitors, revealing a new compound effective in multiple models.

2 citations

C. elegansexperimental assay

𝕏 PostBluesky